Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2001-8-8
pubmed:abstractText
Exogenous application of transforming growth factors-beta (TGF beta) family proteins, including glial cell line-derived neurotrophic factor (GDNF), neurturin, activin, and bone morphogenetic proteins, has been shown to protect neurons in many models of neurological disorders. Finding a tissue source containing a variety of these proteins may promote optimal beneficial effects for treatment of neurodegenerative diseases. Because fetal kidneys express many TGF beta trophic factors, we transplanted these tissues directly into the substantia nigra after a unilateral 6-hydroxydopamine lesion. We found that animals that received fetal kidney tissue grafts exhibited (1) significantly reduced hemiparkinsonian asymmetrical behaviors, (2) a near normal tyrosine hydroxylase immunoreactivity in the lesioned nigra and striatum, (3) a preservation of K(+)-induced dopamine release in the lesioned striatum, and (4) high levels of GDNF protein within the grafts. In contrast, lesioned animals that received grafts of adult kidney tissues displayed significant behavioral deficits, dopaminergic depletion, reduced K(+)-mediated striatal dopamine release, and low levels of GDNF protein within the grafts. The present study suggests that fetal kidney tissue grafts can protect the nigrostriatal dopaminergic system against a neurotoxin-induced parkinsonism, possibly through the synergistic release of GDNF and several other neurotrophic factors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0969-9961
pubmed:author
pubmed:copyrightInfo
Copyright 2001 Academic Press.
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
636-46
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:11493028-Age Factors, pubmed-meshheading:11493028-Animals, pubmed-meshheading:11493028-Behavior, Animal, pubmed-meshheading:11493028-Corpus Striatum, pubmed-meshheading:11493028-Dopamine, pubmed-meshheading:11493028-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:11493028-Fetal Tissue Transplantation, pubmed-meshheading:11493028-Glial Cell Line-Derived Neurotrophic Factor, pubmed-meshheading:11493028-Kidney, pubmed-meshheading:11493028-Kidney Transplantation, pubmed-meshheading:11493028-Male, pubmed-meshheading:11493028-Nerve Growth Factors, pubmed-meshheading:11493028-Nerve Tissue Proteins, pubmed-meshheading:11493028-Neurons, pubmed-meshheading:11493028-Neuroprotective Agents, pubmed-meshheading:11493028-Oxidopamine, pubmed-meshheading:11493028-Parkinsonian Disorders, pubmed-meshheading:11493028-Rats, pubmed-meshheading:11493028-Rats, Sprague-Dawley, pubmed-meshheading:11493028-Substantia Nigra, pubmed-meshheading:11493028-Sympatholytics, pubmed-meshheading:11493028-Transplants, pubmed-meshheading:11493028-Tyrosine 3-Monooxygenase
pubmed:year
2001
pubmed:articleTitle
Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats.
pubmed:affiliation
Cellular Neurobiology Branch, National Institute on Drug Abuse, Baltimore, Maryland 21224, USA.
pubmed:publicationType
Journal Article